PATENT CLAIM ANALYSIS

Application Number: 16122015
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["514", "013500"]

Abstract:
Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficienty are disclosed.

Claim (Index 16):
A lyophilized pharmaceutical composition comprising C1 esterase inhibitor, sodium citrate, at least about 2000 U C1 esterase inhibitor and less than about 5000 U C1 esterase inhibitor wherein when said lyophilized composition is reconstituted in sterile water to prepare a solution with a concentration of 400-600 U/mL of C1-esterase inhibitor the solution is suitable for subcutaneous administration to treat HAE, the sodium citrate has concentration of at least 10 mM, and the solution has a pH ranging from 6.5-8.0, and wherein the C1 esterase inhibitor comprises the amino acid sequence of residues 23 to 500 of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15837969', '15837677', '15837938', '15837693', '14855168']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.661334700318734
- 35 USC 102 Novelty (BERT): 0.5092254611176373
- Combined Prediction Score: 0.6461237763986243
- Mean Citation Score: 270.9834
- Max Citation Score: 275.21338
- Similarity Product: 220.7309201397371

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test